Aura Biosciences, Inc. AURA Net proceeds from sales of subsidiary shares
Net proceeds from sales of subsidiary shares at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceInitialPublicOffering.
The official record: Aura Biosciences, Inc.’s 10-K, filed March 24, 2025, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s net proceeds from sales of subsidiary shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s net proceeds from sales of subsidiary shares?
- Aura Biosciences, Inc. (AURA) reported net proceeds from sales of subsidiary shares of $0 in Q4 2024.
- How has Aura Biosciences, Inc.'s net proceeds from sales of subsidiary shares changed year-over-year?
- Aura Biosciences, Inc.'s net proceeds from sales of subsidiary shares decreased by 100.0% year-over-year, from $23.15M to $0.
- What is the long-term trend for Aura Biosciences, Inc.'s net proceeds from sales of subsidiary shares?
- Over 3 years (2021 to 2024), Aura Biosciences, Inc.'s net proceeds from sales of subsidiary shares has grown at a -100.0% compound annual growth rate (CAGR), from $78.7M to $0.